The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).

<h4>Unlabelled</h4>We describe the application of a novel HIV confirmatory testing algorithm to determine the primary efficacy endpoint in a large Phase III microbicide trial. 9385 women were enrolled between 2005 and 2009. Of these women, 537 (6%) had at least one positive HIV rapid tes...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ute Jentsch, Precious Lunga, Charles Lacey, Jonathan Weber, Janet Cairns, Gisela Pinheiro, Sarah Joseph, Wendy Stevens, Sheena McCormack
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2012
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/d3bb77b6915c4ea78981febeb0e6b1f4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:d3bb77b6915c4ea78981febeb0e6b1f4
record_format	dspace
spelling	oai:doaj.org-article:d3bb77b6915c4ea78981febeb0e6b1f42021-11-18T07:06:08ZThe implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).1932-620310.1371/journal.pone.0042322https://doaj.org/article/d3bb77b6915c4ea78981febeb0e6b1f42012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22984401/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Unlabelled</h4>We describe the application of a novel HIV confirmatory testing algorithm to determine the primary efficacy endpoint in a large Phase III microbicide trial. 9385 women were enrolled between 2005 and 2009. Of these women, 537 (6%) had at least one positive HIV rapid test after enrolment. This triggered the use of the algorithm which made use of archived serum and Buffy Coat samples. The overall sample set was >95% complete. 419 (78%) of the rapid test positive samples were confirmed as primary endpoints using a combination of assays for the detection of HIV-specific antibodies (EIA's and Western Blot), and for components of the virus itself (PCR for the detection of nucleic acids and EIA for p24 antigen). 63 (12%) cases were confirmed as being HIV-positive at screening or enrolment and 55 (10%) were confirmed as HIV negative. The testing algorithm confirmed the endpoint at the same visit as that of the first positive rapid test in 90% of cases and at the time of the preceding visit in 10% of cases. Of the 63 cases which were subsequently confirmed to be HIV-1 positive at or before enrolment, 54 specimens contained no detectable HIV antibodies at screening or enrolment. However, 43 were positive using an EIA which detects both HIV antigen and antibody and also had a positive p24 antigen or HIV PCR test, which was highly suggestive of acute infection. There were 6 unusual cases which had undetectable HIV-1 DNA or RNA. In 4 of the 6 cases the presence of HIV-1-specific antibodies was confirmed by Western Blot. One of these cases with an indeterminate Western Blot was a previous vaccine trial participant. The algorithm served the objectives of the study well and can be recommended for use in determining HIV as an endpoint in clinical trials.<h4>Trial registration</h4>ISRCTN.org ISRCTN 64716212.Ute JentschPrecious LungaCharles LaceyJonathan WeberJanet CairnsGisela PinheiroSarah JosephWendy StevensSheena McCormackPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 9, p e42322 (2012)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Ute Jentsch Precious Lunga Charles Lacey Jonathan Weber Janet Cairns Gisela Pinheiro Sarah Joseph Wendy Stevens Sheena McCormack The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
description	<h4>Unlabelled</h4>We describe the application of a novel HIV confirmatory testing algorithm to determine the primary efficacy endpoint in a large Phase III microbicide trial. 9385 women were enrolled between 2005 and 2009. Of these women, 537 (6%) had at least one positive HIV rapid test after enrolment. This triggered the use of the algorithm which made use of archived serum and Buffy Coat samples. The overall sample set was >95% complete. 419 (78%) of the rapid test positive samples were confirmed as primary endpoints using a combination of assays for the detection of HIV-specific antibodies (EIA's and Western Blot), and for components of the virus itself (PCR for the detection of nucleic acids and EIA for p24 antigen). 63 (12%) cases were confirmed as being HIV-positive at screening or enrolment and 55 (10%) were confirmed as HIV negative. The testing algorithm confirmed the endpoint at the same visit as that of the first positive rapid test in 90% of cases and at the time of the preceding visit in 10% of cases. Of the 63 cases which were subsequently confirmed to be HIV-1 positive at or before enrolment, 54 specimens contained no detectable HIV antibodies at screening or enrolment. However, 43 were positive using an EIA which detects both HIV antigen and antibody and also had a positive p24 antigen or HIV PCR test, which was highly suggestive of acute infection. There were 6 unusual cases which had undetectable HIV-1 DNA or RNA. In 4 of the 6 cases the presence of HIV-1-specific antibodies was confirmed by Western Blot. One of these cases with an indeterminate Western Blot was a previous vaccine trial participant. The algorithm served the objectives of the study well and can be recommended for use in determining HIV as an endpoint in clinical trials.<h4>Trial registration</h4>ISRCTN.org ISRCTN 64716212.
format	article
author	Ute Jentsch Precious Lunga Charles Lacey Jonathan Weber Janet Cairns Gisela Pinheiro Sarah Joseph Wendy Stevens Sheena McCormack
author_facet	Ute Jentsch Precious Lunga Charles Lacey Jonathan Weber Janet Cairns Gisela Pinheiro Sarah Joseph Wendy Stevens Sheena McCormack
author_sort	Ute Jentsch
title	The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
title_short	The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
title_full	The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
title_fullStr	The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
title_full_unstemmed	The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).
title_sort	implementation and appraisal of a novel confirmatory hiv-1 testing algorithm in the microbicides development programme 301 trial (mdp301).
publisher	Public Library of Science (PLoS)
publishDate	2012
url	https://doaj.org/article/d3bb77b6915c4ea78981febeb0e6b1f4
work_keys_str_mv	AT utejentsch theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT preciouslunga theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT charleslacey theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT jonathanweber theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT janetcairns theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT giselapinheiro theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT sarahjoseph theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT wendystevens theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT sheenamccormack theimplementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT utejentsch implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT preciouslunga implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT charleslacey implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT jonathanweber implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT janetcairns implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT giselapinheiro implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT sarahjoseph implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT wendystevens implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301 AT sheenamccormack implementationandappraisalofanovelconfirmatoryhiv1testingalgorithminthemicrobicidesdevelopmentprogramme301trialmdp301
_version_	1718423946263527424

The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301).

Ejemplares similares